Roche says FDA approves HPV self-test in US
BERLIN (Reuters) – Swiss drugmaker Roche on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. Screening for HPV can help identify women who are at risk of developing cervical cancer at an earlier stage. (Reporting by Rachel More, writing by Andrey Sychev)










